Evidence map›Paper›PMID 26418191›Full record

ArticleInternational journal of cardiology2016

Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction.

Nadeem Ahmed, Jamie Layland, David Carrick, Mark C Petrie, Margaret McEntegart, Hany Eteiba, Stuart Hood, Mitchell Lindsay, Stuart Watkins, Andrew Davie and 7 more

2 registry-linked trialsOpen access · hybridAbstract readMulticenter Study
In one paragraph

Article in International journal of cardiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01764334 phase4unknown statusnot on this map

A Developmental Clinical Study of Management Guided by Coronary Angiography Combined With Fractional Flow Reserve (FFR) Measurement Versus Management Guided by Coronary Angiography Alone(Standard Care) in Patients With Non-ST Elevation MI.

TypeinterventionalSponsorNHS National Waiting Times Centre BoardRan2011 to 2020Enrolled350ConditionsNonST Elevation Myocardial Infarction, Myocardial InfarctionArmsFractional flow reserve
NCT02072850 active not recruitingnot on this map

Cardiac Magnetic Resonance Imaging: New Pathological Insights and Their Functional and Clinical Significance in ST Elevation Acute Myocardial Infarction.

TypeobservationalSponsorNHS National Waiting Times Centre BoardRan2011 to 2031Enrolled324ConditionsAcute ST-elevation Myocardial InfarctionArmsCoronary pressure wire, Magnetic resonance imaging of the heart
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Systematic review and meta-analysis of side effects and severe complications caused by intracoronary pressure measurement.Clinical research in cardiology : official journal of the German Cardiac Society · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Observational
  14. Article
  15. Article
  16. Ischemic Heart Disease: Noninvasive Imaging Techniques and Findings.Radiographics : a review publication of the Radiological Society of North America, Inc
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Nadeem AhmedInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK; Department of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK.
Jamie LaylandInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK; Department of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK.
David CarrickInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK; Department of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK.
Mark C PetrieInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK; Department of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK.
Margaret McEntegartInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK; Department of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK.
Hany EteibaInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK; Department of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK.
Stuart HoodInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK; Department of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK.
Mitchell LindsayInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK; Department of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK.
Stuart WatkinsInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK; Department of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK.
Andrew DavieDepartment of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK.
Ahmed MahrousDepartment of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK.
Jaclyn CarberryInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK.
Vannesa TengInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK.
Alex McConnachieRobertson Centre for Biostatistics, University of Glasgow, Glasgow, Scotland, UK.
Nick CurzenUniversity Hospital Southampton Foundation Trust, Southampton, UK; Faculty of Medicine, University of Southampton, Southampton, UK.
Keith G OldroydInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK; Department of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK.
Colin BerryInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, UK; Department of Cardiology, Golden Jubilee National Hospital, Glasgow G81 4DY, Scotland, UK. Electronic address: colin.berry@glasgow.ac.uk.
Golden Jubilee National Hospital · GBUniversity of Glasgow · GBUniversity Hospital Southampton NHS Foundation Trust · GB

Funding

British Heart Foundation PG/11/2/28474British Heart Foundation PG/11/55/28999Chief Scientist OfficeMedical Research Council MR/N003403/1
6 · The paper itself

Abstract

aimsCoronary guidewire-based diagnostic assessments with hyperemia may cause iatrogenic complications. We assessed the safety of guidewire-based measurement of coronary physiology, using intravenous adenosine, in patients with an acute coronary syndrome.

methodsWe prospectively enrolled invasively managed STEMI and NSTEMI patients in two simultaneously conducted studies in 6 centers (NCT01764334; NCT02072850). All of the participants underwent a diagnostic coronary guidewire study using intravenous adenosine (140 μg/kg/min) infusion for 1-2 min. The patients were prospectively assessed for the occurrence of serious adverse events (SAEs) and symptoms and invasively measured hemodynamics were also recorded.

results648 patients (n=298 STEMI patients in 1 hospital; mean time to reperfusion 253 min; n=350 NSTEMI in 6 hospitals; median time to angiography from index chest pain episode 3 (2, 5) days) were included between March 2011 and May 2013. Two NSTEMI patients (0.3% overall) experienced a coronary dissection related to the guidewire. No guidewire dissections occurred in the STEMI patients. Chest symptoms were reported in the majority (86%) of patient's symptoms during the adenosine infusion. No serious adverse events occurred during infusion of adenosine and all of the symptoms resolved after the infusion ceased.

conclusionsIn this multicenter analysis, guidewire-based measurement of FFR and IMR using intravenous adenosine was safe in patients following STEMI or NSTEMI. Self-limiting symptoms were common but not associated with serious adverse events. Finally, coronary dissection in STEMI and NSTEMI patients was noted to be a rare phenomenon.

Indexed as

AdenosineCoronary AngiographyFemaleFractional Flow Reserve, MyocardialHemodynamicsHumansMaleMicrocirculationMiddle AgedMyocardial InfarctionPercutaneous Coronary InterventionProspective StudiesUnited KingdomVascular ResistanceVasodilator AgentsAdenosineVasodilator AgentsAdenosineBlood pressure (BP)Heart rate (HR)Non ST-elevation myocardial infarction (NSTEMI)Percutaneous coronary intervention (PCI)ST-elevation myocardial infarction (STEMI)

Identifiers

PMID26418191
PMCPMC4669307
OpenAlexW1870015808

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.